Psychedelics in Psychiatry, the Nursing Influence, and the Future of Psychedelic Therapies
Journal of the American Psychiatric Nurses Association January 29, 2024 DOI: 10.1177/10783903231222930 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Citations | 4 |
| Key findings | Nurses have been involved with psychedelic-assisted therapies in the past and are fully capable of providing a wide range of roles upon anticipated approval as a treatment modality. |
Abstract
Objective: Psychedelics and psychedelic-assisted therapies (PATs) are on the cusp of becoming medicalized treatment modalities within the United States, both as potential U.S. Food and Drug Administration (FDA)-approved treatment and therapeutic options outside the medical model, through decriminalization efforts within individual states. Bringing with it a paradigm shift in the delivery of health care for both physical and mental health treatment. A workforce of highly trained facilitators will be needed to meet the anticipated demand for this type of treatment and nurses can play a key role in meeting this demand. This article serves to introduce psychedelic-assisted therapies to psychiatric-mental health nurses as we start to see this new field emerge.
Method: Review of published literature and other media.
Results: Results based on historical data, modern applications, and future considerations.
Conclusions: Nurses have been involved with psychedelic-assisted therapies in the past and are fully capable of providing a wide range of roles upon the anticipated approval as a treatment modality.